¡¡
Pharma Koreana, Korea pharmaceutical news & reports, was established in 1991 and is now Korean leading pharmaceutical business newsletter. For the past years, Pharma Koreana has consistently provided senior executives in the pharmaceutical industry with the inside knowledge they need to compete and win! Readers are subscribers at the pinnacle of their careers as well as the rising stars of tomorrow. They turn to Pharma Koreana for its unique monthly package of Korean pharmaceutical news, analyses, commentaries and data. ¡¡
          
¡¡
There are 21 News items on Display.
Latest News¡¡

HighLight
1. Korea Green Cross¡¯ Hunterase for the treatment of Hunter syndrome approved by the KFDA

Korea Green Cross announced that the KFDA recently approved Hunterase (idursulfase-beta) inj., the world¡¯s second drug for the treatment of ..
 

January 25th, 2012
2. Top ten local pharmaceutical firms estimated to record an average sales growth of just 1.2% in 2011

Analysis of data from securities companies showed that the top ten local pharmaceutical firms were estimated to record an average sales gr ..
 

January 25th, 2012
3. Drug price policy directed towards survival of just 50 R&D-focused pharmaceutical firms

The Vice-Minister of the Ministry for Health, Welfare and Family Affairs (MIHWAF) recently gave a lecture on the government¡¯s healthcare pol ..
 

January 25th, 2012
more ...
Business News
4. Combined reimbursement claim for forty major drugs of multinational pharmaceutical firms forecasted to decrease by 206.3 billion won

The reimbursement prices of forty products out of the top hundred drugs, in terms of health insurance drug reimbursement claimed by multinat ..
 

February 7th, 2012
5. Exports of drugs increased by 23.5% in 2011

According to the Korea Pharmaceutical Traders Association (KPTA), exports of drugs, etc., amounted to $2.85 billion in 2011 which represents ..
 

February 7th, 2012
6. CJ¡¯s combination drug of clopidogrel and aspirin approved by the KFDA

CJ Pharm recently obtained the KFDA approval for Closone (clopidogrel hydrogen sulfate + aspirin) cap., Korea¡¯s first combination drug of cl ..
 

February 7th, 2012
7. Daewoong and Dong-A expected to be severely impacted by the government¡¯s reformation of the drug pricing system

According to the recent deliberations of the drug reimbursement evaluation committee within the Health Insurance Review Agency (HIRA), the r ..
 

February 7th, 2012
8. Patent-expired original drugs show solid performance despite challenge of generic drugs

Based on the UBIST data, sales of prescription drugs for out-patients were analyzed. As a result, it was found that new generic drugs did no ..
 

February 7th, 2012
more ...
Policy and Regulatory
9. Anti-tumor and anti-dementia drugs presented as promising therapeutic categories in the senior-friendly pharmaceutical industry

According to a report recently released by the Korea Health Industry Development Institute (KHIDI), the senior-friendly pharmaceutical indus ..
 

February 7th, 2012
10. KFDA continues to operate its on-spot training program for GMP validation

The KFDA announced its plan for validation-related on-spot training tour for year 2012. As shown in the table, the KFDA will carry out train ..
 

January 31st, 2012
more ...
Bio industry news
11. Samsung Biologics to increase capital by issuing new stocks

Samsung Biologics, a biopharmaceutical joint venture established in April 2011 by Samsung Group and Quintiles (the U.S.), recently announced ..
 

February 7th, 2012
12. Kolon Life Science and Viromed developing gene therapies

Kolon Life Science, a KOSDAQ-listed bio-company, is currently conducting phase II clinical trials for TissueGene-C, a cell-mediated gene the ..
 

January 31st, 2012
13. Aprogen¡¯s biosimilar to be marketed in Japan jointly by Nichi-Iko and Sanofi

Schnell Biopharm recently announced that Nichi-Iko Pharm, Japan¡¯s leading generic drug company, and Sanofi, the world¡¯s fourth-largest multi ..
 

January 31st, 2012
more ...
R & D
14. National Cancer Center and Sanofi-Aventis Korea to jointly develop new anticancer drugs

The National Cancer Center (NCC) recently announced that ¡®the agency for bridging and development program for cancer therapeutics with syste ..
 

February 7th, 2012
15. KHIDI releases its 2011 annual report for the pharmaceutical industry

The Korea Health Industry Development Institute (KHIDI) analyzed the status of 74 local listed pharmaceutical firms and 28 global pharmaceut ..
 

February 7th, 2012
16. Korea United Pharm to develop a new combination anticancer drug containing a natural substance

Korea United Pharm recently signed an MOU with Professor KANG Keon-wook of College of Pharmacy, Seoul National University, to jointly develo ..
 

February 7th, 2012
more ...
Patent
17. Generic companies lose patent nullification suits against Renexin

The Korean Intellectual Property Tribunal ruled that SK Chemicals¡¯ patent for Renexin (cilostazol + Ginkgo leaf extract) tab., a combination ..
 

January 25th, 2012
18. Sewon Cellontech obtains two Japanese patents related to cell culture facilities

Sewon Cellontech recently obtained two Japanese patents titled ¡®cell manipulation and cultivation equipments for the production of cell th ..
 

January 25th, 2012
19. Bioneer obtains a Korean patent for human milk-derived lactic acid bacteria

Bioneer, a local biotechnology company, recently obtained a Korean patent titled ¡®human milk-derived lactic acid bacteria having probiotic ..
 

January 25th, 2012
more ...
Company profile
20. Summary of Korea Pharmaceutical Manufacturer

Summary of Korea Pharmaceutical Manufacturer (Daewon Pharm & Hanmi Pharm)Please download the attached file.
 

January 26th, 2012
21. Summary of Korea Pharmaceutical Manufacturer

Summary of Korean Pharmaceutical Manufacturer (Jeil Pharm & Cheil Jedang Corp. )Please download the attached file.
 

December 30th, 2011
more ...
¡¡
Pharma Koreana Ltd. 9F, KAMCO Yangjae Tower, 949-3, Dogok-dong Gangnam-gu, Seoul 135-270, Korea Tel:(82)2-554-9591 Fax:(82)2-563-8289 ¡¡ ¡¡

Email:Pkinfo@Pharmakoreana.com
Subscriptions:Pkinfo@Pharmakoreana.com
¡¡
¡¡